Skip to main content
Trevor Gerson, MD, Neurology, Kansas City, KS

Trevor Gerson MD

Headache


Headache Neurologist

Join to view full profile
  • 3901 Rainbow BlvdKansas City, KS 66160

  • Phone+1 913-588-5000

  • Fax+1 816-302-9939

Dr. Gerson is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Children's Mercy Kansas City
    Children's Mercy Kansas CityNeurology, 2020
  • University of Missouri-Kansas City School of Medicine
    University of Missouri-Kansas City School of MedicineFellowship, Neurology, 2020
  • University of Kansas School of Medicine
    University of Kansas School of MedicineResidency, Neurology, 2015 - 2019
  • Chicago Medical School at Rosalind Franklin University of Medicine and Science
    Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2015

Certifications & Licensure

  • KS State Medical License
    KS State Medical License 2015 - 2027
  • MO State Medical License
    MO State Medical License 2019 - 2027
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Gold Humanism Award Gold Humanism Honors Society, 2015

Publications & Presentations

PubMed

Press Mentions

  • Nerivio Device Cleared for Pediatric Migraine Treatment
    Nerivio Device Cleared for Pediatric Migraine TreatmentNovember 15th, 2024
  • FDA Expands the Age Indication for Nerivio® as the First-and-Only REN Wearable for Migraine Treatment for Children Aged Eight and Above
    FDA Expands the Age Indication for Nerivio® as the First-and-Only REN Wearable for Migraine Treatment for Children Aged Eight and AboveNovember 14th, 2024
  • New Study Evaluates Use of the Nerivio® REN Wearable for Treatment of Migraine in Children Under the Age of 12
    New Study Evaluates Use of the Nerivio® REN Wearable for Treatment of Migraine in Children Under the Age of 12July 25th, 2024

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: